title: Assessment of urinary N-acetyl-β-glucosaminidase as an early marker of contrast-induced nephropathy.
abstract: Early detection and timely intervention are important for improving contrast-induced nephropathy (CIN) prognosis. Whether urinary N-acetyl-β-glucosaminidase (NAG) is a useful marker for early detection of CIN was investigated in 590 patients undergoing diagnostic coronary angiography (CA) and/or therapeutic percutaneous coronary intervention (PCI) for acute coronary syndromes or stable angina, and who received low-osmolality nonionic contrast agent. Urinary NAG, osmolality and serum creatinine were measured before and 1, 2 and 6 days after contrast agent exposure. CIN occurred in 33 patients; its incidence in high-risk patients (pre-existing renal dysfunction with/without diabetes mellitus) was significantly higher than in others. In patients with CIN, urinary NAG and serum creatinine levels on days 1 and 2 were significantly higher than at baseline and compared with patients without CIN; mean levels were gradually returning to baseline by day 6. Compared with serum creatinine, urinary NAG levels peaked earlier in CIN patients and increased much more. The results suggest that, following CA and/or PCI, CIN occurs to a certain degree and that NAG may be a useful early CIN marker as it is noninvasive, simple, inexpensive and sensitive.
authors.affiliation: Department of Nephrology, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
authors.forename: L
authors.initials: L
authors.lastname: Ren
authors.forename: J
authors.initials: J
authors.lastname: Ji
authors.forename: Y
authors.initials: Y
authors.lastname: Fang
authors.forename: S H
authors.initials: SH
authors.lastname: Jiang
authors.forename: Y M
authors.initials: YM
authors.lastname: Lin
authors.forename: J
authors.initials: J
authors.lastname: Bo
authors.forename: J Y
authors.initials: JY
authors.lastname: Qian
authors.forename: X H
authors.initials: XH
authors.lastname: Xu
authors.forename: X Q
authors.initials: XQ
authors.lastname: Ding
mesh_terms: D000118:Acetylglucosaminidase / Q000652:urine*; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D015415:Biomarkers / Q000652:urine; D002681:China / Q000453:epidemiology; D003287:Contrast Media / Q000009:adverse effects*; D017023:Coronary Angiography / Q000009:adverse effects; D003404:Creatinine / Q000097:blood; D003920:Diabetes Mellitus / Q000453:epidemiology; D005260:Female; D006801:Humans; D015994:Incidence; D007674:Kidney Diseases / Q000097:blood / Q000139:chemically induced* / Q000201:enzymology* / Q000652:urine; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration
chemical_list: D015415:Biomarkers; D003287:Contrast Media; D003404:Creatinine; D000118:Acetylglucosaminidase